2Snider RH Jr, Nylen ES, Becket KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization[J]. J Investig Med, 1997,45(9) :552-560.
3Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the caleitonink-1 gene in multiple tissues in response to sepsis[J]. J Clin Endocrinol Metab, 2001,86( 1 ) :396-404.
4Oberhoffer M, Stonans I, Russwt, rm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitra[J]. J Lab Clin Med, 1999.134(1 ) :49-55.
5Whang KT, Vath SD,Becker KL, et al.Procalcitoin and proinflammatory cytokine interactions in sepsis[ J].Shock, 2000,14(1 ) :73-78.
6Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased byprocalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[ J]. Crit Care Med, 1998,26 (6) : 1001-1006.
7Martinez JM, Becket KL, Mailer B, et al. Improved physiologic and metabolic parameters and increased survival with late procaleiton in immunoneutralization in septic pigs. In : 41 st Interscience Conference on Antimicrehiol Agents and Chemotherapy (ICAAC). Chicago, IL,2001.
8Brunkhorst FM, Heins U, Forycki ZF. Kinetics of pmcalcitonin in iatrogenic sepsis[ J]. Intensive Care Med, 1998,24(8) :888-889.
9Schroder J, Staubach KH, Zabel P, et al. Procalcitonin as a marker of severity in septic shock[J]. Langenbecks Arch Sum. 384( 1 ) :33-38.
10Marchini G, Berggren V, Djilalik-Merzoug R, et al. The birth process initiates an acute phase reaction in the fetus-newbom infant[J]. Aeta Paediatr, 2000, 89(9):1082-1086.
